Artiva Biotherapeutics (ARTV) Receivables - Other (2023 - 2025)
Historic Receivables - Other for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $79000.0.
- Artiva Biotherapeutics' Receivables - Other fell 4015.15% to $79000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $79000.0, marking a year-over-year decrease of 4015.15%. This contributed to the annual value of $146000.0 for FY2024, which is 7983.43% down from last year.
- As of Q3 2025, Artiva Biotherapeutics' Receivables - Other stood at $79000.0, which was down 4015.15% from $30000.0 recorded in Q2 2025.
- Artiva Biotherapeutics' Receivables - Other's 5-year high stood at $892000.0 during Q2 2024, with a 5-year trough of $30000.0 in Q2 2025.
- In the last 3 years, Artiva Biotherapeutics' Receivables - Other had a median value of $146000.0 in 2024 and averaged $319571.4.
- Data for Artiva Biotherapeutics' Receivables - Other shows a peak YoY increase of 4015.15% (in 2025) and a maximum YoY decrease of 9663.68% (in 2025) over the last 5 years.
- Over the past 3 years, Artiva Biotherapeutics' Receivables - Other (Quarter) stood at $724000.0 in 2023, then crashed by 79.83% to $146000.0 in 2024, then tumbled by 45.89% to $79000.0 in 2025.
- Its Receivables - Other stands at $79000.0 for Q3 2025, versus $30000.0 for Q2 2025 and $234000.0 for Q1 2025.